nuclear receptor is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-06-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Fracture mechanics is the field of mechanics concerned with the study of the propagation of cracks in materials. It uses methods of analytical solid mechanics to calculate the driving force on a crack and those of experimental solid mechanics to characterize the material's resistance to fracture. Theoretically, the stress ahead of a sharp crack tip becomes infinite and cannot be used to describe the state around a crack. Fracture mechanics is used to characterise the loads on a crack, typically using a single parameter to describe the complete loading state at the crack tip. A number of different parameters have been developed. When the plastic zone at the tip of the crack is small relative to the crack length the stress state at the crack tip is the result of elastic forces within the material and is termed linear elastic fracture mechanics (LEFM) and can be characterised using the stress intensity factor
== Pathophysiology == As of 2026, the pathophysiology of fibromyalgia had not yet been elucidated. The prevailing view was that the fibromyalgia resulted from an amplification of pain by the central nervous system, but other hypotheses have also been suggested.
== Principles and training methods == Strength training follows the fundamental principle that involves repeatedly exercising a muscle group. This is typically done by contracting the muscles during an exercise and then returning to the starting position. This process may be repeated for several repetitions until the muscles reach the point of failure. Strength training typically follows the principle of progressive overload, in which muscles are subjected to gradually increasing resistance over time to stimulate adaptation and growth. They respond by growing larger and stronger. People who are beginning strength training are in the process of training the neurological aspects of strength, including the ability of the brain to generate a rate of neuronal action potentials that will produce a muscular contraction that is close to the maximum of the muscle's potential.
== Works cited == Smallwood, Frank (1983). The Other Candidates: Third Parties in Presidential Elections. University Press of New England. p. 317. ISBN 0-87451-256-5. 6,898 David McReynolds David McReynolds. Presidential Elections since 1789. Congressional Quarterly. 1991. p. 248. ISBN 0-87187-609-4. Busky, Donald F. (2000). Democratic socialism: A global survey. Greenwood Publishing Group. ISBN 0-275-96886-3. Freeman, Joe (2008). We Will be Heard: Women's Struggles for Political Power in the United States. Rowman & Littlefield Publishers. p. 263. ISBN 978-0-7425-5607-2. 3,882 Willa Kenoyer Willa Kenoyer.
Sources: en.wikipedia.org
Football team equipment handler. Exhibits false humility. "The man oozed slime. He was always touching and petting his face and grimy red hair and other things that were just wrong." (Uriah Heep) Mr Armstrong – Middle school teacher and guidance counselor who has learned Demon's history and works to help him with school. (Dr Marcus Strong) Ms Annie – "Hippie" art teacher at Demon's high school who encourages his artistic abilities and encourages him in his comic strip creation. Wife of Mr Armstrong. (Annie) Vester Spencer – Owns the hardware and feed store where Demon works. He dies of complications of lung cancer, leaving Dori alone. (Francis Spenlow) Dori – Daughter of Vester Spencer whom Demon falls in love with. Both she and Demon are addicted to OxyContin and other prescription drugs. (Dora Spenlow) Jip – Dori's dog who plays a big role in her life and affections. (Jip) Rose Dartell – Fast Forward’s friend who despises Demon due to jealousy over his relationship with Fast Forward. (Miss Rosa Dartle) Mouse – Very small, fast-talking friend of Fast Forward. (Miss Mowcher)
Additionally, the titres of specific antibodies raised by DNA vaccination are lower than those obtained after vaccination with a recombinant protein. However, DNA immunization-induced antibodies show greater affinity to native epitopes than recombinant protein-induced antibodies. In other words, DNA immunization induces a qualitatively superior response. Antibodies can be induced after one vaccination with DNA, whereas recombinant protein vaccinations generally require a boost. DNA immunization can be used to bias the TH profile of the immune response and thus the antibody isotype, which is not possible with either natural infection or recombinant protein immunization. Antibody responses generated by DNA are useful as a preparative tool. For example, polyclonal and monoclonal antibodies can be generated for use as reagents.
Since then, it has been applied worldwide to treat patients who are in need of new skin to treat massive burns and traumatic skin wounds, those undergoing plastic surgery of the skin, as well as others who have certain forms of skin cancer. In clinical practice, a thin graft sheet manufactured from the active collagen scaffold is placed on the injury site, which is then covered with a thin sheet of silicone elastomer that protects the wound site from bacterial infection and dehydration. The graft can be seeded with autologous cells (keratinocytes) in order to accelerate wound closure, however the presence of these cells is not required for regenerating the dermis. Grafting skin wounds with Integra leads to the synthesis of normal vascularized and innervated dermis de novo, followed by re-epithelization and formation of epidermis. Although early versions of the scaffold were not capable of regenerating hair follicles and sweat glands, later developments by S.T Boyce and coworkers led to solution of this problem. The mechanism of regeneration using an active collagen scaffold has been largely clarified. The scaffold retains regenerative activity provided that it has been prepared with appropriate levels of the specific surface (pore size in range 20-125 μm), degradation rate (degradation half-life 14 ± 7 days) and surface chemical features (ligand densities for integrins α1β1 and α2β1 must exceed approximately 200 μΜ α1β1 and α2β1 ligands).
Sources: en.wikipedia.org
In 2015, Rachel reunites with Yoshi and they spend the night together catching up and later looking for his missing backpack. When asked about her falling out with Shira, Rachel, while looking a bit guilty, hastily says it was just teen stuff, but that Shira got mad for "no reason". She and Yoshi wind up ending their night in a make out session, which causes Yoshi to ejaculate and ruin his sperm sample for Kendra’s IVF treatment, and when Shira finds out Baby caused him to do so she becomes even more hurt and angry and cements her decision to use an anonymous donor. Danny Burstein as Uncle Barry, Naomi's boisterous, obnoxious uncle by marriage with her aunt Sylvia, the sister of Naomi's mother. Avia Fields as Walter and Benjamin Hooper-Schwooper, the hyperactive twin sons of Kendra and Shira, born in 2015 or 2016. Julie Klausner as Carol Schwartz, one of Naomi's older sisters. Zoe Lister-Jones as Susan Schwartz, one of Naomi's older sisters.
Juniper is an online weight-management company operated by Eucalyptus Health. It provides telehealth-based care. Its core offerings include weight management and menopause-related services. The service operates in Australia, the United Kingdom, Germany, Japan and Canada. Juniper's programs are accessed through an online intake and clinician-led consultation. The program is combined with lifestyle support (referred to as health coaching), and may include prescription treatment with glucagon-like peptide-1 (GLP-1) receptor agonist medications, such as semaglutide (sold as Wegovy or Ozempic) and tirzepatide (Mounjaro), where clinically appropriate and allowed by local laws.
=== Category:EC 1.1 (act on the CH-OH group of donors) === Category:EC 1.1.1 (with NAD+ or NADP+ as acceptor) Alcohol Dehydrogenase (NAD) EC 1.1.1.1 Alcohol Dehydrogenase (NADP) EC 1.1.1.2 Homoserine Dehydrogenase EC 1.1.1.3 Aminopropanol Oxidoreductase EC 1.1.1.4 Diacetyl Reductase EC 1.1.1.5 Glycerol Dehydrogenase EC 1.1.1.6 Propanediol-Phosphate Dehydrogenase EC 1.1.1.7 Glycerol-3-Phoshitiendopene Dehydrogenase (NAD+) EC 1.1.1.8 D-xylulose reductase EC 1.1.1.9 L-xylulose reductase EC 1.1.1.10 Lactate dehydrogenase EC 1.1.1.27 Malate dehydrogenase EC 1.1.1.37 Isocitrate dehydrogenase EC 1.1.1.42 HMG-CoA reductase EC 1.1.1.88 Category:EC 1.1.2 (with a cytochrome as acceptor) Category:EC 1.1.3 (with oxygen as acceptor) Glucose oxidase EC 1.1.3.4 L-Gulonolactone oxidase EC 1.1.3.8 Thiamine oxidase EC 1.1.3.23 Xanthine oxidase EC 1.1.3.32 Category:EC 1.1.4 (with a disulfide as acceptor) Category:EC 1.1.5 (with a quinone or similar compound as acceptor) Category:EC 1.1.99 (with other acceptors)
== Structure == As shown in the figure to the right, the periplasmic space in gram-negative or diderm bacteria is located between the inner and outer membrane of the cell. The periplasm contains peptidoglycan and the membranes that enclose the periplasmic space contain many integral membrane proteins, which can participate in cell signaling. Furthermore, the periplasm houses motility organelles such as the flagellum, which spans both membranes enclosing the periplasm. The periplasm is described as gel-like due to the high abundance of proteins and peptidoglycan. The periplasm occupies 7% to 40% of the total volume of diderm bacteria, and contains up to 30% of cellular proteins. The structure of the monoderm periplasm differs from that of diderm bacteria as the so-called periplasmic space in monoderm bacteria is not enclosed by two membranes but is rather enclosed by the cytoplasmic membrane and the peptidoglycan layer beneath. For this reason, the monoderm periplasmic space is also referred to as the inner-wall zone (IWZ). The IWZ serves as the first destination of translocation for proteins being transported across the monoderm bacterial cell wall.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.